Sienna Biopharmaceuticals, a Westlake Village biotech company, announced positive results Friday for its topical pre-treatment to standard laser hair removal, referred to as SNA-001.

The recent trial involving 65 patients included men and women with white, gray, blonde, light red and light brown hair...

Join our Membership to get the full story.

Are you a current Member? Sign In